Our Clinical Trials
We conduct many clinical trials with the goal of developing therapies for allergic disorders and asthma.
Our studies include a wide range of patients, representing a diverse group of ages, ethnicities and socioeconomic backgrounds.
Our Center offers equal opportunity to all people with allergies, so long as they are eligible based on study parameters.
Participate in Prescreening at the Sean N. Parker Center for Allergy & Asthma at Stanford University
Condition: Allergies, Food Allergies, Asthma, Eczema, Atopic Dermatitis, Allergic Rhinitis, Eosinophilic Esophagitis (EOE)
Age Group: 0-90 y/o
Duration: 1 Time Event
Description: We invite people with doctor-diagnosed food allergies, asthma, eczema, allergic rhinitis, eosinophilic esophagitis (EOE), and other allergic conditions to participate in prescreening for allergy and asthma research at our center.
Contact: If you are interested in learning more about the study or scheduling a prescreening visit, you can call us at (650) 521-7237 or contact us at snpcenterallergy.inquiry@stanford.edu
SEAL
SEAL (Stopping Eczema and ALlergy) Study
Study Objective: To test if proactive use of topical skin creams is more effective than common atopic dermatitis (eczema) treatment methods at preventing eczema and food allergies.
Who is Eligible: Any child up to 12 weeks of age is welcomed. Our physicians will determine the participant's eligibility based on the participant's skin and other criteria in the clinic. Parental consent is required prior to enrollment.
Study Duration: 36 months (4 clinic visits)
Study Principal Investigators: Sayantani B. Sindher, MD
Study Sponsor: Stanford University School of Medicine
Compensation for participation is provided.
Contact for more information and to schedule a pre-screening visit:
Clinic Email:
snpcenterallergy.inquiry@stanford.edu
Clinic Phone: (650) 521-7237
The SYSTEMAATIC Project (Systems-based Multidisciplinary Assessment of Adversity and Toxic Stress for Individualized Care)
Study Objectives:
Develop a Toxic Stress Assessment Profile that identifies disruptions in the neurologic, endocrine, and immune pathways so that we can provide an integrated, biological understanding of toxic stress to support medical and mental health providers in recognizing Adverse Childhood Experiences (ACEs) as a universal health issue.
Who is Eligible:
Adults (18-75 years of age) are welcome. Participants will be selected who have experienced either 0 or ≥4 ACEs. Our physicians will further determine the participant's eligibility based on the participant's medical history and other criteria in the clinic. Consent is required prior to enrollment.
Study Duration:
12 months (2 clinic visits, 3 remote questionnaires)
Study Principal Investigators:
Sayantani B. Sindher, MD
Study Sponsor:
California Initiative to Advance Precision Medicine, and Stanford University School of Medicine.
Compensation for participation is provided.
Click here to view the full flyer.
Contact for more information and to schedule a screening visit:
Clinic Email: snpcenterallergy.inquiry@stanford.edu
Clinic Phone: (650) 521-7237
For complaints, concerns, or participant's rights, contact 1-866-680-2906
Spokin
The Sean N. Parker Center is proud to be a Verified Partner with Spokin, a leading resource in the food allergy community. Spokin’s free iOS app connects the food allergy community in a fast and fun way to resources including food, restaurants, bakeries, travel and more. Download the app to explore over 65,000 user reviews in over 80 countries, top rated product and travel guides, recipes and more. Visit spokin.com to learn more.
FARE Patient Registry
Join the FARE Patient Registry! Answer survey questions about your food allergy experiences and take an important step that benefits both you and the entire food allergy community!
Your answers will help food allergy researchers understand the disease and search for new treatments.
You’ll have the option to learn about clinical trials and connect with researchers.
Sean N. Parker Center is proud to be a part of the FARE Clinical Network conducting novel research on treatments, diagnostics, prevention, and improvements to care.
Click HERE to get started!